期刊文献+

石斛合剂对老年糖尿病大鼠GCK、GLUT-2的影响 被引量:3

Effects of Shihu Heji on expressions of GCK、GLUT-2 of rats with senile diabetes
下载PDF
导出
摘要 目的:观察石斛合剂(DC)对老年糖尿病大鼠血糖、GSP水平以及GCK、GLUT-2表达的影响,探讨其治疗糖尿病的作用机制。方法:Wistar雌性大鼠分为正常组(9只)、模型组(12只)、石斛合剂低剂量组(12只)、石斛合剂高剂量组(12只)、二甲双胍对照组(10只),检测各组大鼠血糖、GSP水平,取胰腺组织,免疫组化检测GLUT-2、GCK阳性面积、IOD。结果:与模型组比较,石斛合剂低、高剂量组血糖、GSP水平显著降低(P<0.05,P<0.01),GCK、GLIT-2阳性面积、IOD显著升高(P<0.05,P<0.01)。结论:DC具有使胰岛GCK与GLUT-2表达上调的作用,可能是石斛合剂调节糖代谢作用的机制之一。 Objective:To observe the effects of Shihu Heft (DC)on contents of blood sugar, GSP and expressions of GCK, GLUT-2 of rats with senile diabetes,and approach its mechanism in treating diabetes. Methods:Wistar female rats were randomly divided into normal control group(n=9 ), model group(n= 12 ), metformin group(n= 10), large dosage group( n=12 ) and small dosage group(n=12)of DC. Then contents of blood sugar, GSP, positive areas and IOD of GCK,GLUT-2 of pan- creatic tissue were detected. Results : Compared with model group,contents of blood sugar, GSP were decreased, positive areas and IOD of GCK,GLUT-2 of pancreatic tissue were increased in large dosage and small dosage of DC group(P〈0.05, P〈0.01 ). Conclusion : DC can regulate glucose metabolism through up-regulating the expressions of GCK and GLUT-2 in pancreatic island.
机构地区 福建中医药大学
出处 《山西中医学院学报》 2014年第4期27-29,共3页 Journal of Shanxi College of Traditional Chinese Medicine
关键词 石斛合剂 GCK GLUT-2 糖尿病 DC GCK GLUT-2 diabetes
  • 相关文献

参考文献6

二级参考文献33

  • 1林求诚,叶盈,方素钦,王耀华,沈宗国.真菌降脂素治疗脂质代谢紊乱的临床研究[J].中国中西医结合杂志,1995,15(5):281-283. 被引量:8
  • 2林兰.中西医结合糖尿病学(第1版)[M].北京:中国医药科技出版社,1997.33.
  • 3[1]Fajans SS, Bell GI, Polonsky KS, et al. Molecular mechanism and clinical pathophysiology of maturity-onset diabetes of the young. N Engl J Med, 2001, 345(13): 971
  • 4[2]Froguel P, Zouali H, Vionnet N, et al. Familial hyperglycemia due to mutations in glucokinase: definition of a subtype of diabetes mellitus. N Engl J Med, 1993, 328: 697
  • 5[3]Yamagata K, Oda N, Kaisaki PJ, et al. Mutations in the hepatocyte nuclear factor-1α gene in maturity-onset diabetes of the young (MODY3). Nature, 1996, 384:455
  • 6[4]Yamagata K, Furuta H, Oda N, et al. Mutations in the hepatocyte nuclear factor-4α gene in maturity-onset diabetes of the young (MODY1). Nature, 1996, 384: 458
  • 7[5]Lehto M. Bitzen PO, Isoma B, et al. (1999) Mutation in the HNF-4α gene affects insulin secretion and triglyceride metabolism. Diabetes, 48: 423
  • 8[6]Stoffers DA, Ferrer J, Clarke WL, et al. Early-onset type II diabetes mellitus (MODY4) linked to IPF1. Nat Genet, 1997, 17: 138
  • 9[8]Hani EH, Stoffers DA, Chevre JC, et al. Defective mutations in the insulin promoter factor-1 (IPF-1) gene in late-onset type 2 diabetes mellitus. J Clin Invest, 1999, 104: R41
  • 10[9]Macfarlane WM, Frayling TM, Ellard S, et al. Missense mutations in the insulin promoter factor-1 gene predispose to type 2 diabetes. J Clin Invest, 1999, 104: R33

共引文献32

同被引文献86

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部